VIRNasdaq United States
Market cap
$1.492 B
$8.82 +0.63%
Close of 7 Aug 2026
Revenue
$68.6M
#2641 by revenue
Earnings
-$438.0M
Loss-making
Shares outstanding
169,215,958
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Vir Biotechnology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.